RP-382

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameRP-382
Drug Alias NameRP-382
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHeparin antagonistsBlood coagulation stimulants
TargetsHeparin
Therapy Area/IndicationsShock, Hemorrhagic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRepligen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRepligen Corp
Active IndicationsN/A
Inactive IndicationsShock, Hemorrhagic

Other Information

ATC CodeN/A
Related LinksN/A